Skip to content

STUDIO PHARMA

Inactive
Private limited companyfounded 2006Artemeersstraat 11, 9880 Aalter, BelgiumKBO/BCE: BE 0883.309.219

Inactive since 02-05-2026; last annual accounts for fiscal year 2024.

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
39 d early
2024
73 d early
2023
14 d early
2022
41 d early
2021
18 d early
2020
16 d early
2019
32 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

STUDIO PHARMA was incorporated on 5 September 2006.1 Total assets rose from EUR 463,082 in 2018 to EUR 918,815 in 2024 and headcount from 0.8 to 5 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2024

Go further with this company

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, abbreviated schema

Equity
€814,971▼ 37.3%
2023 · €1.3m
Total assets
€918,815▼ 47.6%
2023 · €1.8m
Net result
€694,614▲ 83.5%
2023 · €378,479
Working capital
€755,996▼ 33.8%
2023 · €1.1m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Operating result€285,724▲ 18.4%€289,681▲ 1.4%€447,967▲ 54.6%€561,956▲ 25.4%€686,637▲ 22.2%
Net result€201,164above the sector's middle half▲ 24.5%€206,506above the sector's middle half▲ 2.7%€307,508above the sector's middle half▲ 48.9%€378,479above the sector's middle half▲ 23.1%€694,614above the sector's middle half▲ 83.5%
Equity€701,356above the sector's middle half▲ 33.6%€827,407above the sector's middle half▲ 18.0%€1.0mabove the sector's middle half▲ 21.0%€1.3mabove the sector's middle half▲ 29.7%€814,971within the sector's middle half▼ 37.3%
Total assets€1.2mabove the sector's middle half▲ 84.5%€1.3mabove the sector's middle half▲ 8.4%€1.5mabove the sector's middle half▲ 15.3%€1.8mabove the sector's middle half▲ 17.7%€918,815within the sector's middle half▼ 47.6%
Debt€490,335▲ 306%€463,847▼ 5.4%€487,435▲ 5.1%€453,974▼ 6.9%€103,845▼ 77.1%
Working capital€574,682above the sector's middle half▲ 35.2%€701,200above the sector's middle half▲ 22.0%€878,537above the sector's middle half▲ 25.3%€1.1mabove the sector's middle half▲ 30.0%€755,996above the sector's middle half▼ 33.8%
Solvency58.9%within the sector's middle half▼ 22.4pp64.1%within the sector's middle half▲ 5.2pp67.3%within the sector's middle half▲ 3.2pp74.1%within the sector's middle half▲ 6.8pp88.7%above the sector's middle half▲ 14.6pp
Current ratio5.64above the sector's middle half▲ 1.136.73above the sector's middle half▲ 1.096.12above the sector's middle half▼ 0.618.00above the sector's middle half▲ 1.878.28above the sector's middle half▲ 0.28
Return on assets (ROA)16.9%within the sector's middle half▼ 8.1pp16.0%within the sector's middle half▼ 0.9pp20.7%within the sector's middle half▲ 4.7pp21.6%within the sector's middle half▲ 0.9pp75.6%above the sector's middle half▲ 54.0pp
Staff (FTE)2.3above the sector's middle half▲ 43.8%3.5▲ 52.2%3.4▼ 2.9%3.9▲ 14.7%5above the sector's middle half▲ 28.2%
above within below the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Why a figure moved sharply
  • 2024 Net result +84% on 2023. The accounts now follow the abbreviated schema, last year the micro schema.
Result per fiscal year
Operating resultNet result
€0€200,000€400,000€600,000Operating result 2020: €285,724€285,724Net result 2020: €201,164€201,164Operating result 2021: €289,681€289,681Net result 2021: €206,506€206,506Operating result 2022: €447,967€447,967Net result 2022: €307,508€307,508Operating result 2023: €561,956€561,956Net result 2023: €378,479€378,479Operating result 2024: €686,637€686,637Net result 2024: €694,614€694,61420202021202220232024€0€200,000€400,000€600,000Operating result 2022: €447,967€448,000Net result 2022: €307,508€308,000Operating result 2023: €561,956€562,000Net result 2023: €378,479€378,000Operating result 2024: €686,637€687,000Net result 2024: €694,614€695,000202220232024
The operating result has risen four years in a row; 2024 is 22% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €918,815
Fixed assets €58,975 ▼ 86.8%
Current assets €859,840 ▼ 34.1%
Equity and liabilities €918,815
Equity €814,971 ▼ 37.3%
Debt €103,845 ▼ 77.1%
Debt's share of the balance-sheet total falls from 25.9% to 11.3%. Equity and debt are lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€708,595▲
2023 · €595,740
Cash flow
€716,572▲
2023 · €412,262
Debt to equity
0.13▼
2023 · 0.35
ROE
85.2%▲
2023 · 29.1%
Interest coverage
100.17▲
2023 · 86.68
Debt ≤ 1 year
€103,845▼
2023 · €163,202
Debt > 1 year
€0▼
2023 · €289,572
Income taxes
€182,556▼
2023 · €184,526
Staff costs
€368,451▲
2023 · €317,931
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 58 lines
Balance sheet Code20232024
Assets
Total assets20/58€1.8m€918,815▼
Fixed assets21/28€448,065€58,975▼
Tangible fixed assets22/27€447,965€58,875▼
Land and buildings22€378,532€0▼
Plant, machinery and equipment23€303€2,092▲
Furniture and vehicles24€44,480€42,004▼
Other tangible fixed assets26€24,650€14,779▼
Financial fixed assets28€100€100=
Current assets29/58€1.3m€859,840▼
Amounts receivable within one year40/41€240,477€197,737▼
Trade receivables40€240,477€197,604▼
Other amounts receivable41€0€133▲
Current investments50/53€949,779€502,686▼
Cash at bank and in hand54/58€109,011€146,676▲
Deferred charges and accrued income490/1€5,826€12,742▲
Equity and liabilities
Total equity and liabilities10/49€1.8m€918,815▼
Equity10/15€1.3m€814,971▼
Contributions10/11€12,400€12,400=
Reserves13€1.3m€802,571▼
Tax-exempt reserves132€126,300€126,300=
Distributable reserves133€1.2m€676,271▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€453,974€103,845▼
Amounts payable after more than one year17€289,572€0▼
Financial debts170/4€289,572€0▼
Amounts payable within one year42/48€163,202€103,845▼
Current portion of amounts payable after more than one year42€25,515€0▼
Trade debts44€41,567€28,988▼
Suppliers440/4€41,567€28,988▼
Taxes, remuneration and social security45€56,862€42,556▼
Taxes450/3€29,355€7,714▼
Remuneration and social security454/9€27,507€34,842▲
Other amounts payable47/48€39,259€32,300▼
Accrued charges and deferred income492/3€1,200€0▼
Income statement Code20232024
Remuneration, social security and pensions62€317,931€368,451▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€33,784€21,958▼
Other operating charges640/8€4,201€5,513▲
Gross operating margin9900€917,872€1.1m▲
Operating profit (loss)9901€561,956€686,637▲
Financial income75/76B€7,921€197,606▲
Recurring financial income75€7,921€197,606▲
Financial charges65/66B€6,873€7,074▲
Recurring financial charges65€6,873€7,074▲
Profit (loss) for the period before taxes9903€563,004€877,170▲
Income taxes67/77€184,526€182,556▼
Profit (loss) for the period9904€378,479€694,614▲
Transfer from tax-exempt reserves789€77,700€42,100▼
Transfer to tax-exempt reserves689€42,100€42,100=
Profit (loss) for the period to be appropriated9905€414,079€694,614▲
Appropriation of the result
Profit (loss) to be appropriated9906€414,079€694,614▲
Transfer from equity791/2€49,958€1.2m▲
Transfer to equity691/2€383,256€676,271▲
To other reserves6921€383,256€676,271▲
Profit to be distributed694/7€80,781€1.2m▲
Return on contributions (dividend)694€49,958€1.2m▲
Employees696€30,823€0▼
Other beneficiaries697-€18,343
Social balance
Average headcount (FTE)9087-5.0

The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Remuneration, social security and pensions62-€215,184€298,132€317,931€368,451▲ 15.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29,135€34,164€32,403€33,784€21,958▼ 35.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€0----
Other operating charges640/8-€3,937€4,764€4,201€5,513▲ 31.2%
Gross operating margin9900€496,754€542,967€783,266€917,872€1.1m▲ 17.9%
Operating profit (loss)9901€285,724€289,681€447,967€561,956€686,637▲ 22.2%
Financial income75/76B-€13,025€10,670€7,921€197,606▲ 2,395%
Recurring financial income75€4,146€13,025€10,670€7,921€197,606▲ 2,395%
Financial charges65/66B-€6,633€5,921€6,873€7,074▲ 2.9%
Recurring financial charges65€4,955€6,633€5,921€6,873€7,074▲ 2.9%
Profit (loss) for the period before taxes9903€284,915€296,073€452,716€563,004€877,170▲ 55.8%
Income taxes67/77€83,751€89,567€145,208€184,526€182,556▼ 1.1%
Profit (loss) for the period9904€201,164€206,506€307,508€378,479€694,614▲ 83.5%
Transfer from tax-exempt reserves789--€35,600€77,700€42,100▼ 45.8%
Transfer to tax-exempt reserves689-€42,100€42,100€42,100€42,100=
Profit (loss) for the period to be appropriated9905€159,064€164,406€301,008€414,079€694,614▲ 67.7%
Line20202021202220232024Change
Assets
Total assets20/58€1.2m€1.3m€1.5m€1.8m€918,815▼ 47.6%
Fixed assets21/28€493,264€467,706€438,936€448,065€58,975▼ 86.8%
Intangible fixed assets21€0-----
Tangible fixed assets22/27€493,264€467,606€438,836€447,965€58,875▼ 86.9%
Land and buildings22-€411,022€394,777€378,532€0▼ 100%
Plant, machinery and equipment23-€643€473€303€2,092▲ 591%
Furniture and vehicles24-€11,082€10,244€44,480€42,004▼ 5.6%
Other tangible fixed assets26-€44,860€33,342€24,650€14,779▼ 40.0%
Financial fixed assets28-€100€100€100€100=
Current assets29/58€698,427€823,548€1.0m€1.3m€859,840▼ 34.1%
Amounts receivable within one year40/41€96,796€147,078€169,655€240,477€197,737▼ 17.8%
Trade receivables40-€147,078€169,558€240,477€197,604▼ 17.8%
Other amounts receivable41--€97€0€133-
Current investments50/53€323,192€452,568€661,393€949,779€502,686▼ 47.1%
Cash at bank and in hand54/58€274,234€220,308€214,951€109,011€146,676▲ 34.6%
Deferred charges and accrued income490/1-€3,594€3,985€5,826€12,742▲ 119%
Equity and liabilities
Total equity and liabilities10/49€1.2m€1.3m€1.5m€1.8m€918,815▼ 47.6%
Equity10/15€701,356€827,407€1.0m€1.3m€814,971▼ 37.3%
Contributions10/11-€12,400€12,400€12,400€12,400=
Reserves13€688,956€815,007€989,085€1.3m€802,571▼ 37.6%
Tax-exempt reserves132-€155,400€161,900€126,300€126,300=
Distributable reserves133-€659,607€827,185€1.2m€676,271▼ 41.7%
Profit (loss) carried forward14-€0€0€0€0-
Amounts payable17/49€490,335€463,847€487,435€453,974€103,845▼ 77.1%
Amounts payable after more than one year17€365,212€340,299€315,087€289,572€0▼ 100%
Financial debts170/4-€340,299€315,087€289,572€0▼ 100%
Amounts payable within one year42/48€123,745€122,347€171,448€163,202€103,845▼ 36.4%
Current portion of amounts payable after more than one year42-€24,913€25,212€25,515€0▼ 100%
Trade debts44€5,074€30,884€28,649€41,567€28,988▼ 30.3%
Suppliers440/4-€30,884€28,649€41,567€28,988▼ 30.3%
Taxes, remuneration and social security45-€46,738€71,213€56,862€42,556▼ 25.2%
Taxes450/3-€21,804€41,754€29,355€7,714▼ 73.7%
Remuneration and social security454/9-€24,935€29,459€27,507€34,842▲ 26.7%
Other amounts payable47/48-€19,812€46,374€39,259€32,300▼ 17.7%
Accrued charges and deferred income492/3-€1,200€900€1,200€0▼ 100%
Line20202021202220232024Change
Profit (loss) for the period9904€201,164€206,506€307,508€378,479€694,614▲ 83.5%
+ Depreciation and write-downs630€29,135€34,164€32,403€33,784€21,958▼ 35.0%
Operating cash flow (approximation)€230,299€240,670€339,910€412,262€716,572▲ 73.8%
Investment in fixed assets (approximation)--€8,606-€3,633-€42,912€367,131▲ 956%
Change in cash--€53,926-€5,357-€105,940€37,665▲ 136%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
22-06
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
18-02
State Gazette act Restructuring
Merger · Accounting effect · Power of attorney5 facts ▸
  • Board meeting, 15-01-2026
  • Merger, sister merger by absorption
  • Merger, sister merger by absorption
  • Accounting effect, 01-01-2026
  • Power of attorney, In2pharma NV
2025
19-05
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Highest result since 2018net €694,614 ▲83.5%
Operating result €686,637, net result €694,614, both a record.
17-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
20-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Equity above €1mEq €1.0m ▲21%
5 profitable years in a row build equity to €1.0m.
13-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
15-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
29-06
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Equity above €500,000Eq €524,931 ▲19.4%
2 profitable years in a row build equity to €524,931.
26-06
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
21-06
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
22-06
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 4 acts read
About the unread acts

Of the 4 Belgian State Gazette acts we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 1. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aalter
exact location from the address register On OpenStreetMap
Ground area
2,628 m²
Building footprint
206 m²
Volume, LiDAR
1,113 m³
Parcel 44055A1207/00F000, Flanders · tallest building 9.9 m, ±2 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44055A1207/00F000
ProtectedTownscape or village viewWindmolen Artemeersmolen: omgevingSource ↗
Flanders 2,628 m² 1 · 206 m² 9.9 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.

Structure & network

Connections & network

No current directors or connected companies found in the register.

Acquisitions and mergers

1 transaction
Taken over by:In2pharma NV
BE 0895.730.662merger by absorption · proposal · State Gazette act of 27-02-2026 (3 acts)

Public money · subsidies and aid

Flemish government

2023 · 1 entry · 2,985 EUR awarded · 2,985 EUR paid
Year Entries awardedpaid
2023 1 2,985 EUR2,985 EUR
Schemes
1 entry · 2,985 EUR · 2,985 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 82,646 companies in sector 70200 we hold annual accounts for 52,627. 30,058 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded05-09-2006
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
73300Public relations and communication consultancy
E-invoicing
Reachable via Peppol
Peppol ID 0208:0883309219

The company is no longer active; its Peppol card can remain until its access point withdraws it.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.